Bellevue Group Ag Arcturus Therapeutics Holdings Inc. Transaction History

Bellevue Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$12.26 - $31.17 $16,551 - $42,079	-1,350 Reduced 3.3%	39,550 $623,000
Q1 2022 May 13, 2022	SELL	$17.64 - $39.57 $12,348 - $27,699	-700 Reduced 1.68%	40,900 $1.1 Million
Q4 2021 Feb 10, 2022	BUY	$34.2 - $47.56 $242,820 - $337,676	7,100 Added 20.58%	41,600 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $961,860 - $2.01 Million	34,500 New	34,500 $1.65 Million

178

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $478M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.